Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amphastar Pharmaceuticals (AMPH) Net Cash Flow (2016 - 2026)

Amphastar Pharmaceuticals has reported Net Cash Flow over the past 13 years, most recently at -$46.1 million for Q4 2025.

  • For Q4 2025, Net Cash Flow fell 13.79% year-over-year to -$46.1 million; the TTM value through Dec 2025 reached $18.4 million, up 144.68%, while the annual FY2025 figure was $18.4 million, 144.68% up from the prior year.
  • Net Cash Flow for Q4 2025 was -$46.1 million at Amphastar Pharmaceuticals, down from $28.6 million in the prior quarter.
  • Over five years, Net Cash Flow peaked at $119.8 million in Q3 2023 and troughed at -$126.3 million in Q4 2023.
  • A 5-year average of $3.8 million and a median of $3.7 million in 2024 define the central range for Net Cash Flow.
  • On a YoY basis, Net Cash Flow climbed as much as 1459.14% in 2023 and fell as far as 10738.45% in 2023.
  • Year by year, Net Cash Flow stood at $19.8 million in 2021, then tumbled by 105.89% to -$1.2 million in 2022, then plummeted by 10738.45% to -$126.3 million in 2023, then soared by 67.93% to -$40.5 million in 2024, then dropped by 13.79% to -$46.1 million in 2025.
  • Business Quant data shows Net Cash Flow for AMPH at -$46.1 million in Q4 2025, $28.6 million in Q3 2025, and $4.8 million in Q2 2025.